BR112013003391B8 - Método para diagnosticar câncer pancreático em um indivíduo - Google Patents

Método para diagnosticar câncer pancreático em um indivíduo

Info

Publication number
BR112013003391B8
BR112013003391B8 BR112013003391A BR112013003391A BR112013003391B8 BR 112013003391 B8 BR112013003391 B8 BR 112013003391B8 BR 112013003391 A BR112013003391 A BR 112013003391A BR 112013003391 A BR112013003391 A BR 112013003391A BR 112013003391 B8 BR112013003391 B8 BR 112013003391B8
Authority
BR
Brazil
Prior art keywords
cancer
individual
pancreatic cancer
methods
subject
Prior art date
Application number
BR112013003391A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112013003391B1 (pt
BR112013003391A2 (pt
Inventor
Alaric Williams Stephen
Riel-Mehan Michael
M Ostroff Rachel
Original Assignee
Somalogic Inc
Somalogic Operating Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc, Somalogic Operating Co Inc filed Critical Somalogic Inc
Publication of BR112013003391A2 publication Critical patent/BR112013003391A2/pt
Publication of BR112013003391B1 publication Critical patent/BR112013003391B1/pt
Publication of BR112013003391B8 publication Critical patent/BR112013003391B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
BR112013003391A 2010-08-13 2011-08-12 Método para diagnosticar câncer pancreático em um indivíduo BR112013003391B8 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US37368710P 2010-08-13 2010-08-13
US61/373,687 2010-08-13
US41868910P 2010-12-01 2010-12-01
US61/418,689 2010-12-01
US201161482347P 2011-05-04 2011-05-04
US201161482480P 2011-05-04 2011-05-04
US61/482,347 2011-05-04
US61/482,480 2011-05-04
PCT/US2011/047570 WO2012021795A2 (en) 2010-08-13 2011-08-12 Pancreatic cancer biomarkers and uses thereof

Publications (3)

Publication Number Publication Date
BR112013003391A2 BR112013003391A2 (pt) 2016-07-26
BR112013003391B1 BR112013003391B1 (pt) 2020-03-31
BR112013003391B8 true BR112013003391B8 (pt) 2022-10-25

Family

ID=45565264

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013003391A BR112013003391B8 (pt) 2010-08-13 2011-08-12 Método para diagnosticar câncer pancreático em um indivíduo

Country Status (12)

Country Link
US (3) US20120040861A1 (enExample)
EP (1) EP2603622A4 (enExample)
JP (1) JP5931874B2 (enExample)
KR (1) KR101857462B1 (enExample)
CN (2) CN103415624B (enExample)
AU (3) AU2011289284B2 (enExample)
BR (1) BR112013003391B8 (enExample)
CA (1) CA2804857C (enExample)
IL (1) IL224014A (enExample)
MX (2) MX350533B (enExample)
SG (3) SG187045A1 (enExample)
WO (1) WO2012021795A2 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012006632A2 (en) 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
SG187045A1 (en) 2010-08-13 2013-02-28 Somalogic Inc Pancreatic cancer biomarkers and uses thereof
NL2009015C2 (en) * 2012-04-10 2013-10-15 Biosparq B V Method for classification of a sample on the basis of spectral data, method for creating a database and method for using this database, and corresponding computer program, data storage medium and system.
CA2902841A1 (en) * 2013-03-13 2014-10-02 Creatics Llc Methods and compositions for detecting pancreatic cancer
JP2016513462A (ja) * 2013-03-14 2016-05-16 アボツト・モレキユラー・インコーポレイテツド 細胞作製物及び細胞支持体、及びテラノーシスにおけるその使用
CN103324846A (zh) * 2013-06-13 2013-09-25 浙江加州国际纳米技术研究院绍兴分院 结直肠癌症治疗预后生物标记物的筛选方法
CN103310105A (zh) * 2013-06-13 2013-09-18 浙江加州国际纳米技术研究院绍兴分院 筛选非小细胞肺癌治疗疗效生物标记物的方法
CA2952390A1 (en) * 2013-06-20 2014-12-24 The Trustees Of The University Of Pennsylvania Methods for diagnosing pancreatic cancer
KR101594981B1 (ko) * 2013-10-31 2016-02-17 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
US10330682B2 (en) 2013-10-31 2019-06-25 Sk Telecom Co., Ltd. Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
KR101594980B1 (ko) * 2013-10-31 2016-02-17 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
US9506925B2 (en) 2014-07-02 2016-11-29 Dragon Victory Development Ltd. Specific biomarker set for non-invasive diagnosis of liver cancer
US9885718B2 (en) 2014-07-02 2018-02-06 Dragon Victory Development Ltd. Specific biomarker set for non-invasive diagnosis of liver cancer
WO2016060382A1 (ko) * 2014-10-17 2016-04-21 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
KR20160045547A (ko) 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP2016214239A (ja) * 2015-05-15 2016-12-22 国立大学法人高知大学 膵がんマーカー
CN108138238A (zh) * 2015-07-28 2018-06-08 约翰霍普金斯大学 用于检测胰腺癌的组合物和方法
JP2018532992A (ja) * 2015-09-09 2018-11-08 ソマロジック, インコーポレイテッドSomaLogic, Inc. 個別化薬物治療計画の開発方法、及びプロテオミックプロファイルに基づく標的薬物開発
CA3004657A1 (en) * 2015-11-10 2017-05-18 Exact Imaging, Inc. A system comprising indicator features in high-resolution micro-ultrasound images
JP6498107B2 (ja) * 2015-11-30 2019-04-10 日本電信電話株式会社 分類装置、方法、及びプログラム
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
US20190164631A1 (en) * 2016-05-19 2019-05-30 Simplicitybio Sa Biomarkers signature discovery and selection
JP7057913B2 (ja) * 2016-06-09 2022-04-21 株式会社島津製作所 ビッグデータ解析方法及び該解析方法を利用した質量分析システム
BR112019008270A8 (pt) * 2016-10-28 2023-04-11 Beckman Coulter Inc Sistema de avaliação de preparação de substância
WO2018156973A1 (en) 2017-02-24 2018-08-30 Board Of Regents, The University Of Texas System Assay for detection of early stage pancreatic cancer
CN108931650A (zh) * 2017-05-24 2018-12-04 宜昌市中心人民医院 一种激肽释放酶7在血液中的活性检测方法及其作为诊断胰腺癌的血清标志物上的应用
CN108931651A (zh) * 2017-05-24 2018-12-04 宜昌市中心人民医院 一种激肽释放酶7在血液中的含量检测方法及其作为诊断胰腺癌的血清标志物上的应用
WO2019010429A1 (en) * 2017-07-07 2019-01-10 The Trustees Of The University Of Pennsylvania METHODS OF DIAGNOSING PANCREATIC CANCER
US11062792B2 (en) * 2017-07-18 2021-07-13 Analytics For Life Inc. Discovering genomes to use in machine learning techniques
CN107389776B (zh) * 2017-07-18 2020-06-02 宁波瑞瑧生物科技有限公司 一种用于检测药物分布的分析方法及其应用
US11139048B2 (en) 2017-07-18 2021-10-05 Analytics For Life Inc. Discovering novel features to use in machine learning techniques, such as machine learning techniques for diagnosing medical conditions
KR101830314B1 (ko) 2017-07-26 2018-02-20 재단법인 구미전자정보기술원 인공지능 기반 베이지안 네트워크를 이용한 췌장암 진단에 필요한 정보제공 방법, 컴퓨터 프로그램 및 컴퓨터 판독 가능한 기록 매체
CN109425739B (zh) * 2017-08-31 2022-03-18 复旦大学 一组蛋白作为肿瘤标志物在制备恶性肿瘤诊断试剂和试剂盒中的用途
EP3746772A4 (en) * 2018-01-30 2021-11-10 Peter Madrid COMPUTED GENERATION OF CHEMICAL SYNTHESIS PATHS AND METHODS
EP3776381A4 (en) * 2018-04-13 2022-01-05 Freenome Holdings, Inc. IMPLEMENTATION OF MACHINE LEARNING FOR MULTI-ANALYTE TESTS OF BIOLOGICAL SAMPLES
US12416636B2 (en) 2018-05-31 2025-09-16 University Of Florida Research Foundation, Inc. Personalized treatment of pancreatic cancer
WO2020041748A1 (en) * 2018-08-24 2020-02-27 The Regents Of The University Of California Mhc-ii genotype restricts the oncogenic mutational landscape
EP3853383A1 (en) * 2018-09-19 2021-07-28 Bluestar Genomics, Inc. Cell-free dna hydroxymethylation profiles in the evaluation of pancreatic lesions
CN109919688B (zh) * 2019-03-29 2021-03-05 杭州电子科技大学 一种考虑市场因素的电子烟产品线规划方法
JP7590344B2 (ja) * 2019-04-22 2024-11-26 オービット ジェノミクス， インコーポレーテッド マイクロサテライト解析のための方法およびシステム
EP3959719A4 (en) * 2019-04-26 2022-06-01 Sean Kelly DEVICE FOR PERSONAL PREDICTIVE ENRICHMENT OF A BIOMARKER AND METHODS OF USING IT
CN111584010B (zh) * 2020-04-01 2022-05-27 昆明理工大学 一种基于胶囊神经网络和集成学习的关键蛋白质识别方法
EP4407042A3 (en) 2020-07-10 2024-09-18 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
WO2022056328A1 (en) * 2020-09-10 2022-03-17 Caris Mpi, Inc. Metastasis predictor
CN114250298B (zh) * 2020-09-23 2024-09-24 中国医学科学院北京协和医院 胰腺导管腺癌的dna甲基化标志物及其应用
WO2022139465A1 (ko) * 2020-12-22 2022-06-30 두에이아이(주) 인공지능 라만 분석 기법을 이용한 췌장암 조기진단 방법
EP4327098A1 (en) * 2021-04-21 2024-02-28 Reccan Diagnostics AB Pancreatic cancer detection
CN113096125B (zh) * 2021-05-11 2024-05-31 上海宝藤生物医药科技股份有限公司 低密度脂蛋白试剂浓度的确定方法、装置及存储介质
EP4441746A4 (en) * 2021-11-30 2025-10-22 Venn Biosciences Corp DIAGNOSIS OF PANCREATIC CANCER USING TARGETED QUANTIFICATION OF SITE-SPECIFIC PROTEIN GLYCOSYLATION
EP4457358A1 (en) * 2021-12-30 2024-11-06 SomaLogic Operating Co., Inc. Next-generation sequencing for protein measurement
WO2023196571A1 (en) * 2022-04-08 2023-10-12 The Johns Hopkins University Machine learning detection of hypermetabolic cancer based on nuclear magnetic resonance spectra
EP4536861A1 (en) * 2022-06-10 2025-04-16 City of Hope Biomarkers in pancreatic cancer
KR102651556B1 (ko) * 2022-09-28 2024-03-27 주식회사 휴벳바이오 Ca19-9 수준이 낮은 환자의 췌장암 진단용 조성물
WO2024192491A1 (pt) * 2023-03-23 2024-09-26 Huna Ltda. Treinamento e aplicação de modelos de inteligência artificial para a previsão de ocorrência de câncer em um indivíduo
AU2024257583A1 (en) * 2023-04-19 2025-11-20 Molecular You Corporation Method of diagnosis and treatment of pancreatic cancer
KR20250169643A (ko) * 2024-05-22 2025-12-04 주식회사 베르티스 췌장암의 진단용 신규 바이오마커

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US20040254101A1 (en) * 1995-06-06 2004-12-16 Human Genome Sciences, Inc. Colon specific gene and protein and cancer
WO1998039721A1 (en) 1997-03-07 1998-09-11 University Of Florida Method for diagnosing and staging prostate cancer
WO2000052204A2 (en) 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
CN1232826C (zh) 1999-09-10 2005-12-21 村松乔 早期癌症肿瘤标记
WO2001066690A2 (en) 2000-03-06 2001-09-13 Smithkline Beecham Corporation Novel compounds
US6596503B1 (en) 2000-08-18 2003-07-22 East Carolina University Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
US6631330B1 (en) 2000-08-21 2003-10-07 Assistance Publique-Hopitaux De Paris (Ap-Hp) Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
US6576423B2 (en) * 2000-12-08 2003-06-10 The Board Of Regents Of The University Of Nebraska Specific mucin expression as a marker for pancreatic cancer
JP2004526154A (ja) 2001-03-12 2004-08-26 モノジェン インコーポレイテッド 細胞ベースの検出および病態の判別
AU2002309583A1 (en) 2001-04-18 2002-11-05 Protein Desing Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US7189507B2 (en) 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US7622260B2 (en) 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
WO2003029273A2 (en) 2001-09-28 2003-04-10 Whitehead Institute For Biomedical Research Classification of lung carcinomas using gene expression analysis
US20040241653A1 (en) 2001-12-31 2004-12-02 Elena Feinstein Methods for identifying marker genes for cancer
WO2003078662A1 (en) 2002-03-13 2003-09-25 Genomic Health Gene expression profiling in biopsied tumor tissues
US7601826B2 (en) * 2002-09-30 2009-10-13 Oncotherapy Science, Inc. Genes and polypeptides relating to human pancreatic cancers
US20050260639A1 (en) * 2002-09-30 2005-11-24 Oncotherapy Science, Inc. Method for diagnosing pancreatic cancer
CA2506066A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
CN1726395A (zh) * 2002-12-17 2006-01-25 北京诺赛基因组研究中心有限公司 胰腺癌的特异标记
WO2004055519A2 (en) * 2002-12-17 2004-07-01 Sinogenomax Co. Ltd. Specific markers for pancreatic cancer
WO2004061410A2 (en) 2002-12-18 2004-07-22 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
WO2004063355A2 (en) 2003-01-10 2004-07-29 Protein Design Labs, Inc. Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
AU2003900747A0 (en) 2003-02-18 2003-03-06 Garvan Institute Of Medical Research Diagnosis and treatment of pancreatic cancer
US7767391B2 (en) 2003-02-20 2010-08-03 Genomic Health, Inc. Use of intronic RNA to measure gene expression
US20060134120A1 (en) 2003-02-26 2006-06-22 Mount Sinai Hospital Multiple marker assay for detection of ovarian cancer
US20050095611A1 (en) * 2003-05-02 2005-05-05 Chan Daniel W. Identification of biomarkers for detecting pancreatic cancer
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
JP4680898B2 (ja) 2003-06-24 2011-05-11 ジェノミック ヘルス， インコーポレイテッド 癌再発の可能性の予測
WO2005008213A2 (en) 2003-07-10 2005-01-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
EP1668360A4 (en) 2003-08-15 2007-08-08 Univ Pittsburgh MULTI FACTOR CANCER DETECTION TEST
US7807392B1 (en) 2003-09-15 2010-10-05 Celera Corporation Lung disease targets and uses thereof
WO2005043163A2 (en) 2003-11-04 2005-05-12 Roche Diagnostics Gmbh Method for distinguishing who classified aml subtypes
US20050181451A1 (en) 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
JP4912894B2 (ja) 2004-02-19 2012-04-11 イェール ユニバーシティー プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
CA2558808A1 (en) 2004-03-05 2005-09-22 Rosetta Inpharmatics Llc Classification of breast cancer patients using a combination of clinical criteria and informative genesets
EP2947160B1 (en) 2004-04-09 2017-07-12 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
ES2367311T3 (es) 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
EP1743031A4 (en) 2004-04-26 2008-05-28 Childrens Medical Center BLOOD PLATE BIOMARKERS FOR THE DETECTION OF ILLNESSES
US20070275422A1 (en) * 2004-07-26 2007-11-29 The Board Of Trustees Of The Leland Stanford Jr. U Methods and Compositions for Detecting Pancreatic Disease
AU2005278136A1 (en) 2004-08-02 2006-03-02 Children's Medical Center Corporation Platelet biomarkers for cancer
JP2006053113A (ja) 2004-08-16 2006-02-23 Medical Proteoscope Co Ltd 肺腺癌リンパ節転移診断方法及び診断キット
AU2005304878B2 (en) 2004-11-05 2010-07-08 Genomic Health, Inc. Molecular indicators of breast cancer prognosis and prediction of treatment response
PL1836629T3 (pl) 2004-11-05 2020-06-15 Genomic Health, Inc. Przewidywanie odpowiedzi na chemioterapię z zastosowaniem markerów ekspresji genu
US7862995B2 (en) 2004-12-10 2011-01-04 Targeted Molecular Diagnostics Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
US8632983B2 (en) 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
US20070099209A1 (en) 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20090005268A1 (en) 2005-07-18 2009-01-01 Epigenomics Ag Compositions and Methods for Cancer Diagnostics Comprising Pan-Cancer Markers
US7521195B1 (en) 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof
EP2295571A1 (en) 2005-07-27 2011-03-16 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
US20080305962A1 (en) 2005-07-29 2008-12-11 Ralph Markus Wirtz Methods and Kits for the Prediction of Therapeutic Success, Recurrence Free and Overall Survival in Cancer Therapies
US7582441B1 (en) 2005-10-17 2009-09-01 Celera Corporation Methods and compositions for treating and diagnosing disease
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
US8329408B2 (en) 2005-10-31 2012-12-11 Bayer Healthcare Llc Methods for prognosis and monitoring cancer therapy
JP2009516178A (ja) 2005-11-10 2009-04-16 ユニバーシティー オブ ケンタッキー 肺癌診断アッセイ
US8445198B2 (en) 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
US8014957B2 (en) 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
EP3147665A1 (en) 2005-12-22 2017-03-29 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
NZ593226A (en) 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (efnb2) for colorectal cancer prognosis
CA2637446A1 (en) 2006-01-27 2007-08-09 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
WO2007092433A2 (en) * 2006-02-06 2007-08-16 Tethys Bioscience, Inc. Osteoporosis associated markers and methods of use thereof
WO2007102526A1 (en) * 2006-03-02 2007-09-13 Oncotherapy Science, Inc. Methods for diagnosing pancreatic cancer using reg4 protein
US7908091B2 (en) 2006-03-17 2011-03-15 Prometheus Laboratories Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
WO2007123772A2 (en) 2006-03-31 2007-11-01 Genomic Health, Inc. Genes involved in estrogen metabolism
EP2472258A3 (en) 2006-04-04 2012-11-28 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
WO2007146229A2 (en) 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2008003024A2 (en) 2006-06-28 2008-01-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
WO2008046911A2 (en) 2006-10-20 2008-04-24 Exiqon A/S Novel human micrornas associated with cancer
AU2007322206A1 (en) 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2008086182A2 (en) 2007-01-04 2008-07-17 University Of Rochester Use of gene signatures to design novel cancer treatment regimens
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
KR100846354B1 (ko) 2007-03-21 2008-07-15 (주) 프로탄바이오 혈청 당단백질부터 분리한 폐암 진단용 마커
EP3851856A3 (en) * 2007-03-27 2021-11-03 Immunovia AB Method, array and use thereof
WO2008121340A1 (en) 2007-03-28 2008-10-09 Vermillion, Inc. Methods for diagnosing ovarian cancer
US20100179067A1 (en) 2007-05-18 2010-07-15 Patz Jr Edward F Serum biomarkers for the early detection of lung cancer
WO2008153814A2 (en) * 2007-05-29 2008-12-18 President And Fellows Of Harvard College Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
US7888051B2 (en) 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
US8541183B2 (en) 2007-09-11 2013-09-24 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
US20100267041A1 (en) * 2007-09-14 2010-10-21 Predictive Biosciences, Inc. Serial analysis of biomarkers for disease diagnosis
EP2201363A4 (en) 2007-09-18 2011-03-16 Univ Texas DETECTION OF SPOKEN PROTEINS WITH SECONDARY MODULATION TO DUCTAL CARCINOMA IN SITU OF CHEST
JP5580205B2 (ja) 2007-11-19 2014-08-27 セレラ コーポレーション 肺癌マーカーとその使用
US20090186370A1 (en) 2008-01-18 2009-07-23 Ogle Matthew F Diagnostic biomarkers for vascular aneurysm
GB0803192D0 (en) 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
US8067178B2 (en) 2008-03-14 2011-11-29 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
MX2010014289A (es) * 2008-07-04 2011-01-21 Toshiba Kk Metodo y dispositivo para codificar/descodificar imagen dinamica.
WO2012006632A2 (en) 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
ES2559758T3 (es) 2008-09-09 2016-02-15 Somalogic, Inc. Biomarcadores de cáncer de pulmón y usos de los mismos
US20120143805A1 (en) 2008-09-09 2012-06-07 Somalogic, Inc. Cancer Biomarkers and Uses Thereof
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
JP2012502285A (ja) * 2008-09-15 2012-01-26 ヘルレフ ホスピタル 消化管癌のマーカーとしてのｙｋｌ−４０
WO2010042525A1 (en) 2008-10-06 2010-04-15 Somalogic, Inc. Ovarian cancer biomarkers and uses thereof
US20120165217A1 (en) 2008-10-06 2012-06-28 Somalogic, Inc. Cancer Biomarkers and Uses Thereof
US20100221752A2 (en) 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
EP2362942B1 (en) 2008-10-30 2017-06-21 Luxembourg Institute of Health Biomarkers
EP3467123A3 (en) 2008-11-17 2019-07-31 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US10262103B2 (en) 2008-11-18 2019-04-16 Raphael LEHRER Individualized cancer treatment
WO2010065940A1 (en) 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
EP2264183B1 (en) 2009-06-09 2016-12-07 Gendiag.exe, S.L. Risk markers for cardiovascular disease
WO2010148017A1 (en) 2009-06-15 2010-12-23 Cardiodx, Inc. Determination of coronary artery disease risk.
WO2011022552A2 (en) 2009-08-19 2011-02-24 The Cleveland Clinic Foundation Marker Detection for Characterizing the Risk of Cardiovascular Disease or Complications Thereof
US20120178111A1 (en) 2009-09-23 2012-07-12 Diamandis Eleftherios P Methods and compositions for the detection of lung cancers
EP3124980A1 (en) * 2009-10-01 2017-02-01 Phenomenome Discoveries Inc. Mass spectrophotometric method to diagnose pancreatic cancer
EP2491396A4 (en) 2009-10-22 2013-04-17 Univ California INVESTIGATION OF A FIXED TUMOR LOAD
EP2494364A1 (en) 2009-10-29 2012-09-05 Tethys Bioscience, Inc. Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
WO2011068839A1 (en) * 2009-12-01 2011-06-09 Compendia Bioscience, Inc. Classification of cancers
EP2510116A2 (en) 2009-12-09 2012-10-17 Aviir, Inc. Biomarker assay for diagnosis and classification of cardiovascular disease
SG181806A1 (en) 2010-01-11 2012-07-30 Genomic Health Inc Method to use gene expression to determine likelihood of clinical outcome of renal cancer
WO2011094483A2 (en) 2010-01-29 2011-08-04 H. Lee Moffitt Cancer Center And Research Institute, Inc. Immune gene signatures in cancer
CN102906275A (zh) 2010-02-10 2013-01-30 加利福尼亚大学董事会 肺癌检测的唾液生物标记
US9624547B2 (en) 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
CN103237901B (zh) 2010-03-01 2016-08-03 卡里斯生命科学瑞士控股有限责任公司 用于治疗诊断的生物标志物
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
SG187045A1 (en) 2010-08-13 2013-02-28 Somalogic Inc Pancreatic cancer biomarkers and uses thereof
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途
CA3290895A1 (en) 2011-04-29 2025-11-29 Lung Cancer Proteomics Llc Methods of identification and diagnosis of lung diseases using classification systems and kits thereof
US20130065782A1 (en) 2011-08-22 2013-03-14 Somalogic, Inc. Renal Cell Carcinoma Biomarkers and Uses Thereof
SG10201607331WA (en) 2011-09-30 2016-11-29 Somalogic Inc Cardiovascular risk event prediction and uses thereof
WO2013142114A1 (en) 2012-03-19 2013-09-26 The Brigham And Women's Hosptial, Inc. Growth differentiation factor (gdf) for treatment of diastolic heart failure
EP3330277A3 (en) 2013-11-21 2018-09-26 Somalogic, Inc. Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto

Also Published As

Publication number Publication date
SG187045A1 (en) 2013-02-28
US20180045739A1 (en) 2018-02-15
CA2804857C (en) 2021-07-06
KR20130100096A (ko) 2013-09-09
MX350533B (es) 2017-09-08
MX2013001042A (es) 2013-04-03
US11041866B2 (en) 2021-06-22
CN103415624B (zh) 2017-03-01
US20120040861A1 (en) 2012-02-16
WO2012021795A2 (en) 2012-02-16
CN103415624A (zh) 2013-11-27
CN106198980A (zh) 2016-12-07
AU2011289284A1 (en) 2013-02-21
JP5931874B2 (ja) 2016-06-08
AU2015202907A1 (en) 2015-06-18
AU2016269430A1 (en) 2016-12-22
US20140073522A1 (en) 2014-03-13
SG2014007454A (en) 2014-07-30
KR101857462B1 (ko) 2018-05-14
AU2015202907B2 (en) 2016-09-29
BR112013003391B1 (pt) 2020-03-31
MX341517B (es) 2016-08-24
WO2012021795A3 (en) 2013-09-06
AU2016269430B2 (en) 2018-05-10
EP2603622A4 (en) 2015-04-22
EP2603622A2 (en) 2013-06-19
BR112013003391A2 (pt) 2016-07-26
CN106198980B (zh) 2018-09-07
CA2804857A1 (en) 2012-02-16
JP2013541697A (ja) 2013-11-14
AU2011289284B2 (en) 2015-04-09
SG10201710447QA (en) 2018-02-27
IL224014A (en) 2017-09-28

Similar Documents

Publication Publication Date Title
BR112013003391B8 (pt) Método para diagnosticar câncer pancreático em um indivíduo
BR112014006432B8 (pt) Método in vitro para diagnosticar se um indivíduo tem ou não câncer, método implementado por computador, produto de programa de computador
BR112012032537A2 (pt) biomarcadores de câncer de pulmão e suas utilizações
EP3029153A3 (en) Mesothelioma biomarkers and uses thereof
BR112014007214A8 (pt) Método para determinar a probabilidade de que um indivíduo tenha risco elevado de um evento cardiovascular, método para avaliação do risco de um evento cardiovascular futuro e método implementado por computador para avaliação do risco de um evento cardiovascular
HK1205764A1 (en) Tuberculosis biomarkers and uses thereof
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
GB2478441A (en) Lung cancer biomarkers and uses thereof
HK1259001A1 (zh) 癌症的预後和诊断方法
MX373696B (es) Dispositivos, metodos y equipos de prueba para el analisis electronico de analitos.
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
WO2014201516A3 (en) Biomarker identification
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
AR060121A1 (es) Medio y metodo para predecir la diabetes
BR112014015603B1 (pt) métodos para sondagem de múltiplos alvos em uma amostra biológica e para análise da amostra biológica de multiplexação de alta produtividade.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
EP3907509A3 (en) Diagnosis of early stage pancreatic cancer
CO6311041A2 (es) Un metodo para determinar y monitorear un cancer ginecologico que comprende la determinacion de niveles de biomarcadores en una muestra biologica
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
EP4524553A3 (en) Definitive development diagnostic analysis
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
EP2415877A3 (en) Means and methods for diagnosing pancreatic cancer
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
NZ605561A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2014146035A3 (en) Compositions and methods for cancer diagnosis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/08/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: SOMALOGIC OPERATING CO., INC. (US)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 14A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2846 DE 22-07-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.